软组织与骨肉瘤的进展
Advances in Soft Tissue and Bone Sarcoma.
作者信息
Rutland Catrin S
机构信息
School of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Faculty of Medicine and Health Science, Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
出版信息
Cancers (Basel). 2024 Aug 19;16(16):2875. doi: 10.3390/cancers16162875.
Abstract
This Special Issue on bone and soft tissue sarcomas highlights the latest discoveries in soft tissue and bone cancers from the laboratory through to the clinics, from bench to bedside, and beyond [...].
摘要
本期关于骨与软组织肉瘤的特刊重点介绍了从实验室到临床、从实验台到病床旁以及其他方面的软组织和骨癌的最新发现[……]。
相似文献
1
Advances in Soft Tissue and Bone Sarcoma.软组织与骨肉瘤的进展
Cancers (Basel). 2024 Aug 19;16(16):2875. doi: 10.3390/cancers16162875.
2
Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.免疫疗法：软组织和骨肉瘤治疗的新（和旧）方法。
Oncologist. 2018 Jan;23(1):71-83. doi: 10.1634/theoncologist.2016-0025. Epub 2017 Sep 21.
3
Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.骨肉瘤和软组织肉瘤的淋巴扩散：一项淋巴管造影研究。
Acta Radiol Suppl. 1976;349:1-84.
4
Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.采用基于 DNA/RNA 的临床测序技术检测骨与软组织肉瘤中的新型酪氨酸激酶融合基因作为潜在治疗靶点。
Clin Orthop Relat Res. 2024 Mar 1;482(3):549-563. doi: 10.1097/CORR.0000000000002901. Epub 2023 Nov 28.
5
Soft Tissue Special Issue: Imaging of Bone and Soft Tissue Sarcomas in the Head and Neck.软组织特刊：头颈部骨肉瘤和软组织肉瘤的影像学
Head Neck Pathol. 2020 Mar;14(1):132-143. doi: 10.1007/s12105-019-01102-5. Epub 2020 Jan 16.
6
Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas.肢体软组织肉瘤比骨肉瘤更常见且同样危险。
Rev Bras Ortop (Sao Paulo). 2021 Aug;56(4):419-424. doi: 10.1055/s-0040-1712136. Epub 2020 Sep 25.
7
Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.韩国骨肉瘤和软组织肉瘤的人口统计学、治疗模式变化及治疗结果——一项基于肉瘤特异性机构登记处的分析
Cancer Manag Res. 2021 Nov 24;13:8795-8802. doi: 10.2147/CMAR.S337606. eCollection 2021.
8
Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?平价医疗法案是否与成年人的保险覆盖范围增加和骨与软组织肉瘤的早期诊断有关？
Clin Orthop Relat Res. 2021 Mar 1;479(3):493-502. doi: 10.1097/CORR.0000000000001438.
9
Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients.细针穿刺活检对于肉瘤的初步诊断而言，能否成为开放性活检的实用替代方法？140例患者的经验。
Am J Clin Pathol. 2001 Jan;115(1):59-68. doi: 10.1309/YN14-K8U4-5FLJ-DGJE.
10
Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.用于软组织肉瘤鉴别诊断的荧光原位杂交（FISH）
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):655-660. doi: 10.22034/APJCP.2018.19.3.655.
引用本文的文献
1
Advancing Precision Medicine: The Role of Genetic Testing and Sequencing Technologies in Identifying Biological Markers for Rare Cancers.推进精准医学：基因检测与测序技术在识别罕见癌症生物标志物中的作用
Cancer Med. 2025 Apr;14(8):e70853. doi: 10.1002/cam4.70853.
本文引用的文献
1
An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis.一个免疫相关的十一 RNA -signature 驱动的风险评分模型，用于预测骨肉瘤转移的预后。
Sci Rep. 2024 Jun 11;14(1):13401. doi: 10.1038/s41598-024-54292-6.
2
Identification of hub genes related to metastasis and prognosis of osteosarcoma and establishment of a prognostic model with bioinformatic methods.基于生物信息学方法鉴定与骨肉瘤转移和预后相关的枢纽基因并构建预后模型。
Medicine (Baltimore). 2024 Jun 7;103(23):e38470. doi: 10.1097/MD.0000000000038470.
3
Radiomics in Diagnosis, Grading, and Treatment Response Assessment of Soft Tissue Sarcomas: A Systematic Review and Meta-analysis.软组织肉瘤的诊断、分级和治疗反应评估中的放射组学：系统评价和荟萃分析。
Acad Radiol. 2024 Oct;31(10):3982-3992. doi: 10.1016/j.acra.2024.03.029. Epub 2024 May 21.
4
Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.炎症小体相关基因特征作为骨肉瘤的预后生物标志物。
J Cell Mol Med. 2024 May;28(9):e18286. doi: 10.1111/jcmm.18286.
5
Sarculator: how to improve further prognostication of all sarcomas.骨骼肌肌球蛋白重链：如何进一步提高所有肉瘤的预后预测。
Curr Opin Oncol. 2024 Jul 1;36(4):253-262. doi: 10.1097/CCO.0000000000001051. Epub 2024 Apr 30.
6
Current and future genomic applications for surgeons.外科医生当前和未来的基因组应用。
Ann R Coll Surg Engl. 2024 Apr;106(4):321-328. doi: 10.1308/rcsann.2024.0031.
7
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET.软组织肉瘤的分子影像学：FDG PET 的不断发展的作用。
Semin Nucl Med. 2024 May;54(3):332-339. doi: 10.1053/j.semnuclmed.2024.02.001. Epub 2024 Mar 2.
8
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of soft tissue sarcoma from benign lesions: a systematic review of literature.动态对比增强磁共振成像（DCE-MRI）在软组织肉瘤与良性病变鉴别中的应用：文献系统评价。
Skeletal Radiol. 2024 Jul;53(7):1343-1357. doi: 10.1007/s00256-024-04598-3. Epub 2024 Jan 23.
9
Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods.肉瘤生物标志物发现的最新进展：重点介绍基于新一代测序的方法。
Pathology. 2024 Mar;56(2):274-282. doi: 10.1016/j.pathol.2023.10.015. Epub 2023 Dec 14.
10
Preclinical Models of Visceral Sarcomas.内脏肉瘤的临床前模型。
Biomolecules. 2023 Nov 6;13(11):1624. doi: 10.3390/biom13111624.
Zotero 插件